2CL

64.019997 EUR
0.84
1.33%
Last update Dec 16, 7:30 PM CET
Main market
Day range
62.36000
64.019997
Previous close
63.18000
Open
62.36000
Access this stock data via API
Subscribe
BridgeBio Pharma Inc.
64.02
0.84
1.33%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 102.9M 94.2M 99.4M 5.0M
Cost of revenue 5.6M 3.1M 2.2M 1.8M
Gross profit 97.3M 91.1M 97.2M 3.2M
Operating expense
Research & development 96.2M 94.8M 95.0M 111.1M
Selling general and admin 117.3M 110.1M 90.6M 80.8M
Other operating expenses
Operating income -116.2M -113.8M -88.5M -188.6M
Non operating interest income
Income 5.3M 3.3M 4.6M 4.0M
Expense 41.0M 32.1M 35.9M 25.4M
Other income expense -7.0M -12.3M -24.8M -16.8M
Pretax income -158.9M -154.8M -144.5M -226.9M
Tax provision -1.3M 1.8M
Net income -157.6M -156.6M -144.5M -227.9M
Basic EPS -1.0 -0.9 -1.4
Diluted EPS -1.0 -0.9 -1.4
Basic average shares 162.4M 162.1M 161.4M
Diluted average shares 162.4M 162.1M 161.4M
EBITDA -123.2M -126.9M -89.0M -194.2M
Net income from continuing op. -157.6M -156.6M -144.5M -227.9M
Minority interests 1.9M 1.6M 1.9M 2.0M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 7 hours 14 minutes

12:45
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).